Quick Info
| Profession | Businessman |
|---|---|
| Nationality | Indian |
| Date of Birth | 01/10/1955 |
| Age | 70 years |
| Birthplace | Amreli, Gujarat, India |
Latest News about Dilip Shanghvi
05/05/2026
Sun Pharmaceutical Industries announced a $12 billion all-cash agreement to acquire New Jersey-based Organon & Co., one of India's largest global takeovers. The deal is intended to accelerate Sun Pharma's shift toward specialty treatments and expand its international business, but it also presents a major integration challenge because Organon is a large and complex company.
08/10/2025
A Forbes profile highlighted Dilip Shanghvi's succession planning, noting that his son Aalok had been designated chief operating officer in February. The report also said Sun Pharma had renewed its acquisition strategy by buying Checkpoint Therapeutics, a U.S. maker of an FDA-approved skin cancer drug, for $355 million.
Do you like Dilip Shanghvi?
You can vote only once.
Bio/Wiki
| Full Name | Dilip Shantilal Shanghvi |
|---|---|
| Overview | Dilip Shanghvi is an Indian businessman and the founder of Sun Pharmaceutical Industries Ltd., India's largest pharmaceutical company and one of the world's leading specialty generics manufacturers. He started Sun Pharma in 1983 with a modest capital of ₹10,000, focusing initially on psychiatric drugs, and built it into a global pharmaceutical powerhouse through strategic acquisitions and a strong emphasis on quality and research. |
Physical Stats & More
| Height | 5' 6" (168 cm) |
|---|---|
| Eye Color | Black |
| Hair Color | Gray |
Educational Qualification(s)
| School | J. J. Ajmera High School (now Bhawanipur Gujarati Education Society School), Kolkata, West Bengal |
|---|---|
| College/University | University of Calcutta |
| Qualification | Bachelor of Commerce |
Personal Life
| Religion | Hinduism |
|---|---|
| Ethnicity | Gujarati |
| Caste | Vaishnav Kapol Vania |
| Food Habit | Vegetarian |
Relationships & More
| Marital Status | Married |
|---|---|
| Marriage Date | Year 1982 |
Family
| Father | Shantilal N. Shanghvi (deceased) |
|---|---|
| Mother | Kumud S. Shanghvi (deceased) |
| Spouse | Vibha Shanghvi |
| Children | Aalok Shanghvi (executive director of Sun Pharma), Vidhi Shanghvi (vice president of Sun Pharmaceutical Industries Ltd.) |
Career
| Overview | Dilip Shanghvi is the founder of Sun Pharmaceutical Industries, which started with a modest investment and has grown into a leading pharmaceutical company. His innovative ideas and strong leadership have significantly contributed to the company's rapid expansion. Under his guidance, Sun Pharma became India's largest pharmaceutical company and one of the world's leading specialty generics manufacturers, with a global footprint and a diversified portfolio of products. |
|---|---|
| Awards |
|
Favourites
| Cuisine | South Indian |
|---|---|
| Film | Harry Potter |
Style Quotient
| Car Collection |
|
|---|---|
| Net Worth | $24.9 billion (as of February 2026) |
Some Lesser Known Facts
| 1. Dilip comes from a business family background. | |
| 2. He began his career assisting in his father's wholesale medicine business. | |
| 3. His innovative idea led him to manufacture his own drugs to sell, creating Sun Pharmaceutical Industries. | |
| 4. The company started with an investment of Rs. 10,000 and focused on psychiatry drugs initially. | |
| 5. He played a crucial role in expanding the company internationally by acquiring Caraco Pharma in 1997. | |
| 6. Under his leadership, Sun Pharma acquired Taro Pharmaceutical Industries in 2007. | |
| 7. He was appointed to the Reserve Bank of India's central board committee in January 2018. | |
| 8. In May 2021, he transitioned from Managing Director to a non-executive director and chairman at SPARC. | |
| 9. He is known to be a devoted follower of Shrinathji. | |
| 10. Sun Pharma was founded in 1983 with a small loan from his father and began operations in Vapi, Gujarat. | |
| 11. He led the landmark acquisition of Ranbaxy Laboratories in 2014, which significantly expanded Sun Pharma's global presence and product portfolio. | |
| 12. Sun Pharma announced a $12 billion acquisition of Organon & Co. in 2026, marking one of India's largest global takeovers and a major expansion of its international footprint. |